The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
HealthDay on MSN6h
FDA Approves Omvoh for Moderately to Severely Active Crohn DiseaseThe U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...
WISH-TV on MSN12h
FDA approves Lilly's Omvoh for Crohn's diseaseIndianapolis-based Lilly announced Thursday that the U.S. Food and Drug Administration has approved Omvoh for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback